Everolimus and OSI-906 for Patients With Refractory Metastatic Colorectal Cancer

Clinical trial NCT01154335 · COMPLETED

Trial details

NCT number: NCT01154335
Sponsor: SCRI Development Innovations, LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Colorectal Cancer

Start date: 2010-07-01
Primary completion: 2013-05-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.